Mediators of Inflammation / 2016 / Article / Tab 1

Research Article

Interleukin-27 as a Novel Biomarker for Early Cardiopulmonary Failure in Enterovirus 71-Infected Children with Central Nervous System Involvement

Table 1

Summary of clinical data.

GroupsEV71-infected patientsControls ()
Stage II ()Stage III ()Stage IV ()

Female/male27/2820/2216/1448/47
Age (months), mean ± SD25.31 ± 10.2426.55 ± 11.2326.21 ± 10.4726.11 ± 11.05
High fever (>39°C >3 days at admission), (%)33 (60.00)25 (59.52)20 (66.67)0 (0)
Vomiting, (%)15 (27.27)13 (30.95)13 (43.33)0 (0)
Skin rash, (%)52 (94.55)40 (95.24)29 (96.67)0 (0)
Oral ulcer, (%)53 (96.36)42 (100)29 (96.67)0 (0)
Easily frightened, (%)8 (14.55)10 (23.81)12 (40.00)0 (0)
Depression, (%)16 (29.09)18 (42.86)25 (83.33)0 (0)
Abnormal breathing, (%)9 (16.36)8 (19.05)15 (50.00)0 (0)
Increased heart rate, (%)25 (45.45)26 (61.90)26 (86.67)0 (0)
GLU > 8.3 mmol/L, (%)30 (54.55)30 (71.43)25 (83.33)0 (0)
CRT > 2 s, (%)8 (14.55)25 (59.52)23 (76.67)0 (0)
WBC (×109/L), mean ± SD7.08 ± 3.418.74 ± 3.3311.50 ± 3.376.78 ± 2.27

WBC: white blood cell.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.